Literature DB >> 8623059

Palliative and supportive care of patients with pancreatic cancer.

C L Alter1.   

Abstract

Pancreatic cancer tends to be diagnosed at a relatively late stage of disease and often secondary to significant complaints of pain. In addition there is evidence of higher rates of depressive symptoms at diagnosis in pancreatic cancer than in other forms of cancer. These factors, along with the specific tumor anatomy and pathophysiology of pancreatic cancer make palliative considerations central to the care of patients with the disease. The palliative and supportive approach must first include an aggressive evaluation of pain, mood, and emotional symptoms. Attention should be paid to the specific nature of pain complaints and attempts made to make accurate clinicopathological correlates for the pain. Assessment should be complete and ongoing. Pain treatments include pharmacotherapy, invasive anesthetic and surgical procedures, and supportive attention to side effects and other symptoms of disease and treatment. Depression often appears at higher rates than documented in other cancer patients and can be independent of pain complaints and other symptoms present in the preterminal phases of illness. Depression should be treated with pharmacotherapy and supportive psychotherapy as indicated. Hospice should be considered early on in the treatment relationship and can provide pain and symptom management services as well as play an important role in providing emotional support to the patient and family. Attention to pain, mood, psychological distress, and other quality of life issues can often allow for successful treatment of symptoms and improvement in functioning even in the setting of late stage pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623059

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  6 in total

1.  Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain.

Authors:  Chun-Lei Zhang; Ting-Jie Zhang; Yu-Na Guo; Li-Qiang Yang; Ming-Wei He; Jing-Zhe Shi; Jia-Xiang Ni
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

Review 2.  [Therapy of pancreatic adenocarcinoma].

Authors:  M Böhmig; B Wiedenmann; S Rosewicz
Journal:  Med Klin (Munich)       Date:  1999-11-15

3.  Suicide in patients with pancreatic cancer.

Authors:  Kiran K Turaga; Mokenge P Malafa; Paul B Jacobsen; Michael J Schell; Michael G Sarr
Journal:  Cancer       Date:  2010-09-07       Impact factor: 6.860

Review 4.  Practical recommendations for the management of adenocarcinoma of the pancreas.

Authors:  J R Sporn
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

5.  Pain management of patients with unresectable peripancreatic carcinoma.

Authors:  Rutger C I van Geenen; Claudia M G Keyzer-Dekker; Geertjan van Tienhoven; Huug Obertop; Dirk J Gouma
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

6.  Coping with Stress in Neoplastic Diseases.

Authors:  Dominik Olejniczak; Paulina Mularczyk-Tomczewska; Krzysztof Klimiuk; Agata Olearczyk; Aleksandra Kielan; Anna Staniszewska; Karolina Osowiecka
Journal:  Int J Environ Res Public Health       Date:  2022-08-05       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.